New PET scan could spot deadly lung disease years earlier
NCT ID NCT05452889
First seen Jan 29, 2026 · Last updated May 19, 2026 · Updated 21 times
Summary
This study tests a special PET scan that uses a tracer called 18F-fluoroglutamine to see if it can detect early signs of pulmonary arterial hypertension (PAH), a serious lung blood vessel disease. About 71 adults with or at risk for PAH will get the scan to measure how the tracer is taken up in the heart and lungs. The goal is to create a non-invasive tool that could diagnose PAH earlier and more accurately than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Hospital Clinical and Translational Research Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact
Conditions
Explore the condition pages connected to this study.